SMART Wealth LLC Acquires New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SMART Wealth LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 590 shares of the medical equipment provider’s stock, valued at approximately $290,000.

A number of other hedge funds have also modified their holdings of the business. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. LGT Financial Advisors LLC grew its holdings in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth $37,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.9 %

ISRG stock opened at $539.58 on Monday. The company’s 50 day moving average is $521.82 and its two-hundred day moving average is $479.57. Intuitive Surgical, Inc. has a twelve month low of $320.26 and a twelve month high of $556.23. The stock has a market cap of $192.19 billion, a P/E ratio of 86.75, a PEG ratio of 5.35 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Robert W. Baird increased their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $550.28.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.